Autopsy report · NCT04521335

Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma

“Closed at PI's Request”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 9 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Utah

Sponsor type

University, hospital or other

Conditions

Multiple Myeloma

Interventions

Disulfiram; Copper Gluconate

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
  “Terminated per the PI's request.” (66% match in meaning)
• A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity
  “Terminated per PI's request” (66% match in meaning)
• Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
  “PI retired, study closed” (65% match in meaning)
• Comparison of Low-dose Epidural With Intravenous Narcotic Versus Intravenous Narcotic Alone
  “terminated by PI” (62% match in meaning)
• Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
  “PI closed lab” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.